CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 9,151 enrolled
Drug / intervention
SARS-CoV-2/Influenza/RSV RT-PCRother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04748445
NCT04748445N/ACompleted

Acute Respiratory Illness Surveillance (ARIS) by Monitoring Voice and Illness Symptom Changes Using a Mobile Application in a Low-Interventional Decentralized Study.

Pfizer·observational·Posted Feb 10, 2021·Updated Feb 23, 2024

In Brief

An observational study evaluating SARS-CoV-2/Influenza/RSV RT-PCR for Healthy. Completed, enrolled 9,151 participants across 1 site.

Detailed Summary

The purpose of the AcRIS study is to obtain data to characterize the relationship between symptoms and voice features for (reverse transcription polymerase chain reaction (RT-PCR) confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), influenza virus, or Respiratory Syncytial Virus (RSV) positive participants with acute viral respiratory illness. This data will be used as the basis to build voice and symptom algorithm(s) for detection and monitoring of these illnesses. This would benefit vaccine development across several key disease areas, including SARS-CoV-2, influenza virus and RSV. The study also models concepts of more efficient "flexible" clinical trials involving not only voice capture, but also web-based participant recruitment, enhanced participant engagement, and remote sample collection that could make future clinical studies more efficient. The clinical data obtained in this observational study could provide the documentation of the technology's performance needed to enable its deployment in future interventional studies.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedFeb 10, 2021
Enrollment StartApr 12, 2021
Primary CompletionApr 22, 2022
TodayJul 2, 2026
Enrollment to primary: 1.0 yearsPosted 5.4 years ago

Interventions

SARS-CoV-2/Influenza/RSV RT-PCRother

nasal swab